BACKGROUND: The Prostate CAncer gene 3 (PCA3) assay has shown promise as an aid
in prostate cancer (pCA) diagnosis in identifying men with a high probability of a positive (…

Prostate-specific membrane antigen (PSMA) overexpression theoretically enables targeting
of prostate cancer (PCa) metastases using gallium Ga 68 ( 68 Ga)–labeled PSMA ligands …

Purpose : We developed a preoperative nomogram for prediction of lymph node metastases
in patients with clinically localized prostate cancer. Materials and Methods : The study was a …

Purpose : Men diagnosed with clinically localized prostate cancer have a number of treatment
options available, including watchful waiting, radical prostatectomy and radiation therapy. …

Early-onset prostate cancer (EO-PCA) represents the earliest clinical manifestation of
prostate cancer. To compare the genomic alteration landscapes of EO-PCA with "classical" (elderly…

BACKGROUND: Conventional gray scale ultrasound has a low sensitivity and specificity for
prostate cancer detection. Better imaging modalities are needed. OBJECTIVE: To determine …

BACKGROUND Prostate specific membrane antigen (PSMA) is a suggested target for
antibody‐based therapy of prostate cancer potentially involved in the regulation of cell migration. …

Background Gleason grading is the strongest prognostic parameter in prostate cancer.
Gleason grading is categorized as Gleason ≤6, 3 + 4, 4 + 3, 8, and 9–10, but there is variability …

OBJECTIVES: We explored the yield of saturation biopsy and developed a nomogram predicting
the probability of prostate cancer (PCa) on the basis of saturation biopsy. MATERIALS …

BACKGROUND: A key prerequisite for urinary continence after radical prostatectomy (RP)
is the functional length of the urethral sphincter and the stabilisation of its anatomic position …